Heart Test Laboratories Inc Unit (HSCS)
HeartSciences Inc., formerly known as Heart Test Laboratories, Inc., is a medical technology company focused on applying artificial intelligence to electrocardiography in order to enhance its clinical utility. The company develops AI-ECG solutions designed to help detect impaired cardiac relaxation and other forms of cardiac dysfunction associated with heart disease or age-related changes. Its product lineup includes MyoVista wavECG, a resting 12-lead ECG system that provides diagnostic information related to cardiac dysfunction alongside conventional ECG data, and MyoVista Insights, a cloud-based platform intended to host AI-ECG algorithms on hardware-agnostic ECG systems. Founded in 2007 and headquartered in Southlake, Texas, the company’s common stock is listed on NASDAQ under the symbol HSCS.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-HSCS
|
$2.29
|
-7.4% Downside
|
Fair
|
$10
|
304.9% Upside
|
Bargain
|
Weak
|
—
|
—
|
—
|
0.0%
|
July 24, 2026
|
-0.9x
|
3.0x
|
907.8x
|
8.188 M
|
8.341 M
|
32.1%
|
76.0%
|
-24.8
|
—
|
86.6%
|
